These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 4622116)

  • 1. The clinical application of adjuvant 65.
    Hilleman MR; Woodhour A; Friedman A; Weibel RE; Stokes J
    Ann Allergy; 1972 Mar; 30(3):152-8. PubMed ID: 4622116
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies for safety of adjuvant 65.
    Hilleman MR; Woodhour AF; Friedman A; Phelps AH
    Ann Allergy; 1972 Aug; 30(8):477-83. PubMed ID: 5044500
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiments with depot vaccines].
    Henneberg G
    Arzneimittelforschung; 1965 Sep; 15(9):1003-8. PubMed ID: 4955784
    [No Abstract]   [Full Text] [Related]  

  • 4. The antibody response of pigs to dinitrophenylated bovine IgG administered with a novel type of adjuvant.
    Franĕk F; Simek L
    Eur J Immunol; 1971 Aug; 1(4):300-2. PubMed ID: 5157965
    [No Abstract]   [Full Text] [Related]  

  • 5. New metabolizable immunologic adjuvant for human use. 6. Disposition of radioactivity after administration of labelled vaccine to the rat.
    Porter CC; Titus DC
    Proc Soc Exp Biol Med; 1967 Feb; 124(2):500-3. PubMed ID: 6019886
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
    Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
    Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the antigenicity of influenza-adjuvant-vaccines].
    Marubayashi Y
    Kumamoto Igakkai Zasshi; 1966 Mar; 40(3):291-334. PubMed ID: 5953641
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the activity of various immunologic adjuvant substances].
    Richou R; Lallouette P; Richou H
    Rev Immunol Ther Antimicrob; 1969; 33(3):155-74. PubMed ID: 4979181
    [No Abstract]   [Full Text] [Related]  

  • 11. PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants.
    Ichinohe T; Ainai A; Tashiro M; Sata T; Hasegawa H
    Vaccine; 2009 Oct; 27(45):6276-9. PubMed ID: 19840660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant mixtures for use in food.
    Pongracz G
    Int J Vitam Nutr Res; 1973 Apr; 43(4):517-25. PubMed ID: 4797662
    [No Abstract]   [Full Text] [Related]  

  • 13. A TRIAL OF OIL-ADJUVANT INFLUENZA VACCINE IN A NON-EPIDEMIC SEASON.
    HOWELL RW; STOTT AN
    Br J Ind Med; 1964 Oct; 21(4):259-64. PubMed ID: 14249893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of adjuvant effect of A1PO4 on purified influenza virus hemagglutinins in man.
    Davenport FM; Hennessy AV; Askin FB
    J Immunol; 1968 May; 100(5):1139-40. PubMed ID: 5648476
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
    Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.
    Aucouturier J; Dupuis L; Deville S; Ascarateil S; Ganne V
    Expert Rev Vaccines; 2002 Jun; 1(1):111-8. PubMed ID: 12908518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.
    O'Hagan DT
    Expert Rev Vaccines; 2007 Oct; 6(5):699-710. PubMed ID: 17931151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses to influenza A 2 vaccines in man and vervet monkeys.
    Joosting AC; Winter PA; Hodgson B; Harwin RM; Orchard M
    S Afr J Med Sci; 1971 Jul; 36(1):29-31. PubMed ID: 5002693
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.
    Cox RJ; Madhun AS; Hauge S; Sjursen H; Major D; Kuhne M; Höschler K; Saville M; Vogel FR; Barclay W; Donatelli I; Zambon M; Wood J; Haaheim LR
    Vaccine; 2009 Mar; 27(13):1889-97. PubMed ID: 19368768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early antibody responses of mice given a single injection of emulsified influenza virus vaccine.
    Berlin BS
    J Immunol; 1966 Mar; 96(3):424-9. PubMed ID: 5932576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.